chartexchange

DCTH
Delcath Systems Inc
stockNASDAQ

At CloseNov 18, 2026 3:59:58 PM EST
19.69USD+1.652%(+0.32)591,079
Pre-marketNov 18, 2026 9:28:30 AM EST
19.10USD-1.394%(-0.27)
After-hoursNov 18, 2026 4:00:30 PM EST
19.70USD+0.051%(+0.01)
Loading…
Loading…
685.32M
Healthcare
Medical Devices
CEO
Jennifer Simpson
HQ
New York, NY, USA
Previous Close
$19.37
Beta
1.79
52-Week High
$22.51 2026-11-12
52-Week Low
$8.12 2025-11-20
SMA 50
$16.09
SMA 200
$12.86
Avg. Vol 10D
1.29M
Avg. Vol 30D
632,012
Avg. Vol 90D
536,494
Relative Vol
0.94
32.18M
0.4300%
1,500,000
232
Feb 25, 2027 (98d)
Dec 24, 2019 · 1-for-700 (reverse)
DCTH Profile

delcath systems, inc. (nasdaq- dcth) is a specialty pharmaceutical and medical device company focused on the treatment of primary and metastatic liver cancers. our proprietary product---melphalan hydrochloride for injection for use with the delcath hepatic delivery system (melphalan/hds)---is designed to administer high-dose chemotherapy to the liver while controlling systemic exposure. delcath is in late-stage clinical development in the united states with initial commercial activities in europe, where the melphalan/hds is marketed as a ce marked device under the trade name delcath hepatic chemosat® delivery system for melphalan (chemosat). our commercial strategy for chemosat is to steadily grow clinical adoption in major european markets and utilize physician experience to support appeals for reimbursement. since launch over 250 chemosat treatments have been performed at over 20 leading european cancer centers. in 2016, we launched our focus pivotal study in hepatic dominant ocular

DCTH Performance
PeriodPriceDateChangeBeta
1W21.382026-11-12-7.86%1.534
1M14.372026-10-19+37.09%3.468
3M17.152026-08-19+14.87%2.682
6M10.852026-05-19+81.57%1.695
1Y8.512025-11-19+131.49%1.791
2Y9.912024-11-19+98.79%—
5Y9.502021-11-19+107.37%0.951
DCTH Stock Summary

Delcath Systems Inc (NASDAQ:DCTH) stock price today is $19.70, and today's volume is 591,079. DCTH is up 1.704% today. The 30 day average volume is 632,012. DCTH market cap is $685.32M with 34.79M shares outstanding.